GlassScriptPhysician profile
Vasana Cheanvechai
NPI 1124172622
$5,845.30
in general payments reported to CMS, 2019-2025
32 companies · $402 in 2025
The $402 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $707 · 2020: $905 · 2021: $381 · 2022: $1,095 · 2023: $944 · 2024: $1,411 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,757.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $1,081.79 | 2020-2024 | Afx2 Bifurcated Endograft System, Alto Abdominal Stent Graft System |
| Angiodynamics, INC. | $948.94 | 2019-2025 | Venacure 1470 Pro, Auryon Laser System 100-120 Vac |
| Tactile Systems Technology INC | $627.99 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Csl Behring | $341.97 | 2020-2025 | Kcentra |
| Solventum Corporation | $296.82 | 2024-2025 | V.A.C. Veraflo Cleanse Choice, Prevena, V.A.C. Veraflo |
| Cook Medical LLC | $250.00 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $248.41 | 2020-2022 | |
| Bolton Medical INC | $212.72 | 2024 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Medtronic, INC. | $208.14 | 2024 | Abre, Venaseal |
| Stryker Corporation | $166.63 | 2022 | |
| Janssen Pharmaceuticals, INC | $152.63 | 2019-2023 | Xarelto |
| Becton, Dickinson and Company | $150.32 | 2024 | Venclose Maven Catheter |
| Davol INC. | $141.33 | 2024 | Phasix Mesh |
| Bard Peripheral Vascular, INC. | $136.18 | 2022-2025 | Venclose Maven Catheter, Venovo |
| Eagle Pharmaceuticals, INC. | $127.51 | 2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $113.02 | 2019 | |
| Medline Industries LP | $99.82 | 2019 | |
| Cashflow Solutions, LLC | $86.37 | 2022-2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Silk Road Medical, INC. | $62.39 | 2022 | |
| W. L. Gore & Associates, INC. | $57.19 | 2022 | |
| Kerecis Limited | $55.33 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Medtronic Vascular, INC. | $53.22 | 2019 | |
| Boston Scientific Corporation | $42.36 | 2019-2021 | |
| Terumo Medical Corporation | $42.20 | 2019-2024 | Azur Cx Detachable |
| Organogenesis INC. | $30.05 | 2022-2024 | |
| Acera Surgical, INC. | $25.71 | 2019 | |
| Penumbra, INC. | $20.00 | 2021 | |
| Paratek Pharmaceuticals, INC. | $19.86 | 2019 | |
| Bsn Medical INC | $14.36 | 2022 | |
| Biocompatibles, INC. | $14.20 | 2019 | |
| Acell, INC. | $10.32 | 2020 | |
| Cardiovascular Systems INC. | $7.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vasana Cheanvechai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.